Dermatology · PANCE / PANRE

Allergic and Irritant Contact Dermatitis

Eczematous reaction from skin contact with chemical irritants (ICD) or allergens triggering type IV hypersensitivity (ACD).

Also known as: contact dermatitis, allergic contact dermatitis, irritant contact dermatitis, ACD, ICD, poison ivy

Overview

Inflammatory dermatitis caused by direct contact with an exogenous agent. Two main forms: irritant contact dermatitis (ICD, non-immunologic toxic injury) and allergic contact dermatitis (ACD, T-cell mediated type IV delayed hypersensitivity).

Epidemiology

ICD accounts for ~80% of all contact dermatitis; most common occupational skin disease (hairdressers, healthcare, cleaning, construction, food handling). ACD prevalence ~20%; nickel is the most common allergen worldwide.

Try two board-style Allergic and Irritant Contact Dermatitis questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1DermatologyMedium
A 45-year-old female develops red itchy linear streaks on her arm 2 days after gardening. The pattern follows where leaves brushed her skin. Which of the following is the most likely diagnosis?
  • AAllergic contact dermatitis
  • BAtopic dermatitis
  • CContact urticaria
  • DIrritant contact dermatitis
  • ENummular dermatitis
Reveal answer & full explanation
Correct answer: A — Allergic contact dermatitis
  • AAllergic contact dermatitis✓
  • BAtopic dermatitis
  • CContact urticaria
  • DIrritant contact dermatitis
  • ENummular dermatitis

Why Allergic contact dermatitis is correct

  • Allergic contact dermatitis is a type IV (delayed) hypersensitivity reaction, T-cell mediated, requiring prior sensitization
  • Onset occurs 24–72 hours after re-exposure to the allergen
  • The linear streak pattern following where leaves brushed the skin is characteristic of Toxicodendron (poison ivy/oak/sumac) contact — the urushiol oil causes this linear distribution
  • Treatment: avoid the allergen, topical mid-to-high potency corticosteroids, oral corticosteroids if severe
  • Patch testing identifies the specific causative allergen

Why the others are wrong

  • Irritant contact dermatitis — more common than allergic; non-immunologic (no prior sensitization required); caused by direct cellular damage from soap, detergent, or solvent; typically presents with more burning/stinging rather than pruritus; an acute reaction to a strong irritant appears within minutes to hours of exposure, not 2 days later
  • Nummular dermatitis — chronic, intensely pruritic coin-shaped (discoid) eczematous plaques on the extremities, often in the setting of dry skin; not triggered by plant contact and does not form linear streaks
  • Atopic dermatitis — chronic pruritic eczema in flexural distributions; not caused by plant contact and does not produce linear streaks
  • Contact urticaria — plant contact during gardening can cause it, but contact urticaria (IgE-mediated, as with latex, or nonimmunologic, as with stinging nettle) produces wheals within minutes to an hour of contact that usually fade within hours; a rash appearing 2 days after exposure fits a delayed, T-cell-mediated reaction

Additional high-yield points

  • Most common cause of allergic contact dermatitis in adults: nickel (found in jewelry, snaps, watches)
  • Distinguishing allergic from irritant contact dermatitis: allergic is typically more pruritic and appears 1-3 days after exposure; irritant causes more burning/stinging and, after a single strong exposure, appears within minutes to hours
Question 2DermatologyMedium
A 40-year-old man who clears brush along utility lines has had two or three episodes of poison ivy dermatitis every summer for several years; one was extensive enough to require oral glucocorticoids. During past episodes, new itchy patches kept appearing over several days, on his face and wrists as well as the original streaks on his forearms. He already wears work gloves and long sleeves on the job. His skin is clear today. He asks what will most reduce his outbreaks, because he cannot avoid the plants at work. Which of the following is the most appropriate counseling?
  • AStart allergy shots to build tolerance to urushiol
  • BKeep blister fluid off unaffected skin during each flare
  • CWash skin, clothing, and tools promptly with soap and water
  • DApply hydrocortisone 1% to arms, neck, and face before work
  • ETake a non-sedating oral antihistamine before each shift
Reveal answer & full explanation
Correct answer: C — Wash skin, clothing, and tools promptly with soap and water
  • AStart allergy shots to build tolerance to urushiol
  • BKeep blister fluid off unaffected skin during each flare
  • CWash skin, clothing, and tools promptly with soap and water✓
  • DApply hydrocortisone 1% to arms, neck, and face before work
  • ETake a non-sedating oral antihistamine before each shift

Why Wash skin, clothing, and tools promptly with soap and water is correct

  • Poison ivy dermatitis is a type IV (delayed, T-cell-mediated) allergic contact dermatitis to urushiol, the oily resin in Toxicodendron plants. Once he is sensitized, the dose of urushiol that reaches his skin determines whether he reacts, and every re-contact counts.
  • Urushiol binds to skin within minutes. Washing exposed skin with soap and plenty of water as soon as possible after contact (ideally within minutes, and including under the fingernails) removes resin before it can bind. This is the core recommendation in AAD patient guidance and in CDC/NIOSH guidance for outdoor workers who are exposed to poisonous plants.
  • Urushiol also stays active on gloves, sleeves, boots, and tools for a long time (reportedly years). Gloves and long sleeves protect him only if they are washed, and tools only if they are cleaned, after exposure. Otherwise he touches the resin again every time he picks them up or pulls them off.
  • This also explains his history. The new patches on his face and wrists came from resin carried there by his hands and contaminated gear, plus the normal delay at sites that got less resin. They did not come from the rash itself, so removing the resin is what stops new patches from appearing.

Why the others are wrong

  • Take a non-sedating oral antihistamine before each shift - histamine does not drive a type IV T-cell reaction, so taking an antihistamine first does not stop sensitized skin from reacting to urushiol. Antihistamines barely relieve the itch of allergic contact dermatitis either, apart from a sedating dose at bedtime (the trap is treating poison ivy like a type I allergy).
  • Apply hydrocortisone 1% to arms, neck, and face before work - a topical steroid is not a barrier and does not keep urushiol off the skin, so putting it on beforehand does not prevent the reaction. Hydrocortisone 1% is also too weak to help much once poison ivy dermatitis starts (the trap is thinking a treatment also works as prevention).
  • Keep blister fluid off unaffected skin during each flare - blister fluid contains no urushiol, so it cannot spread the rash to him or anyone else. New lesions appearing over days reflect uneven resin doses and repeated contact with contaminated hands, clothing, and tools. This advice does nothing to reduce his future outbreaks (the trap is the common myth that the rash spreads through its fluid).
  • Start allergy shots to build tolerance to urushiol - desensitization works for some IgE-mediated allergies such as insect venom, and urushiol extracts were tried for poison ivy in the past, but they gave inconsistent protection with side effects, and no urushiol immunotherapy is approved or recommended today. Shots would also do nothing about the resin he keeps re-contacting on his skin and gear (the trap is assuming any allergy can be desensitized).

Additional high-yield points

  • Other accepted preventive measures work alongside prompt washing. They include protective clothing and appropriate gloves (washed after each exposure), and bentoquatam 5% lotion, a barrier applied about 15 minutes before possible exposure and reapplied every few hours.
  • Washing later is still worthwhile even when it is not prompt: it removes any resin that has not yet bound and stops further spread from contaminated gear and pets' fur. The sooner he washes, the better it works.
  • Never burn poison ivy, oak, or sumac. Urushiol carried in the smoke can cause severe reactions in the airway and lungs as well as on the skin.
  • Poison ivy, poison oak, and poison sumac all contain urushiol and cause the same dermatitis. Cross-reactions can also follow contact with mango skin and cashew shells.

That's 2. Get 7,700+ more.

Unlock the full FirstPassPA bank: 7,700+ board-style questions, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.

Start your 7-day free trial →
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Allergic and Irritant Contact Dermatitis outline — plus all 514 diagnoses, 7,700+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Occupational wet work, frequent hand washing, hand sanitizers
  • Atopic dermatitis (impaired barrier → predisposes to ICD and sensitization)
  • Common allergens: nickel, fragrance mix, balsam of Peru, formaldehyde, preservatives (MCI/MI, paraben mix), neomycin, bacitracin, rubber accelerators, p-phenylenediamine (hair dye), urushiol (Toxicodendron — poison ivy/oak/sumac)
  • Photoallergens: sunscreen chemicals (oxybenzone), NSAIDs (ketoprofen), topical antibiotics

Pathophysiology

ICD: direct cytotoxic injury → barrier disruption → release of pro-inflammatory cytokines (IL-1, TNF-α). No sensitization required; severity dose-dependent. ACD: small molecule hapten penetrates skin, binds carrier protein, presented by Langerhans cells in regional lymph nodes → CD4+ T-cell sensitization (1-3 weeks); re-exposure → CD8+ memory T-cell mediated delayed hypersensitivity (24-72 hours) → eczematous response.

Clinical presentation

Symptoms

  • ICD: burning, stinging, soreness; pruritus less prominent
  • ACD: intense pruritus; sometimes burning
  • Onset of ACD: 24-72 h after re-exposure in sensitized patient; ICD can occur within minutes to hours

Signs / physical exam

  • Acute: erythema, edema, vesicles, weeping, crusting
  • Subacute: erythematous scaly papules and plaques
  • Chronic: lichenification, fissuring, hyperpigmentation
  • Distribution matches exposure: linear streaks (poison ivy), earlobes/wrist/belt-line (nickel), hands (occupational), face/eyelids (cosmetics, nail polish transfer), scalp/hairline (hair dye), feet (shoe leather/rubber)

Classic findings

Sharp geometric or linear borders matching the contactant; eyelid involvement from airborne or transferred allergens is highly suggestive of ACD.

Differential diagnosis

  • Atopic dermatitis — Personal/family atopy, flexural distribution, chronic course; AD predisposes to contact dermatitis
  • Nummular dermatitis — Coin-shaped plaques without exposure history
  • Tinea — Annular with central clearing and raised scaly border; KOH positive
  • Cellulitis / erysipelas — Warm, tender, indurated; systemic symptoms; rapid spread; no vesicles
  • Herpes zoster — Grouped vesicles in dermatomal distribution; prodromal pain
  • Dyshidrotic eczema — Deep-seated tapioca-like vesicles on palms/soles/lateral fingers; pruritic
  • Phytophotodermatitis — Streaky linear hyperpigmentation/blistering after lime/celery/citrus exposure + sun (psoralen + UV)

Diagnostic workup

Diagnostic criteria

Clinical pattern + temporal/spatial correlation with exposure; patch test confirms ACD allergen.

Labs

  • Clinical diagnosis based on history and morphology
  • Patch testing (gold standard for ACD): T.R.U.E. test or comprehensive panels (NACDG); read at 48 and 96-120 h
  • Skin biopsy nonspecific (spongiotic dermatitis) — distinguishes from psoriasis or CTCL when atypical

Imaging

  • Not indicated

Diagnostic algorithm

FeatureIrritant (ICD)Allergic (ACD)
MechanismDirect cytotoxic injury — non-immuneType IV delayed hypersensitivity (T-cell)
Prior sensitizationNot requiredRequired (1-3 wk for first exposure)
Onset after exposureMinutes to hours24-72 h (memory response)
Predominant symptomBurning, stingingPruritus
BordersLess distinct; confined to the exposed area (e.g., dry, fissured wet-work hands)Distinct geometric or linear shapes mirroring the contactant (streaks, watchband); can spread beyond the contact site
DiagnosisClinical + exposure historyPatch testing
ExamplesSoap, solvents, wet work, urine/salivaNickel, fragrance, neomycin, urushiol, hair dye
Distinguishing features of irritant vs allergic contact dermatitis.

Treatment

First-line

  • Identify and eliminate offending agent — single most important intervention
  • Topical corticosteroid potency by site: hydrocortisone 1-2.5% (face, folds), triamcinolone 0.1% (trunk, extremities), clobetasol 0.05% (palms, soles, lichenified plaques) — 1-3 weeks
  • Topical calcineurin inhibitor (tacrolimus, pimecrolimus) for face/eyelids/folds or steroid-sparing maintenance
  • Cool compresses (Burow's solution/aluminum acetate) for acute weeping phase
  • Emollients to restore barrier; gloves and barrier creams for occupational ICD
  • Oral antihistamine (sedating, e.g., hydroxyzine) at night for sleep — minimal direct effect on itch

Severe / widespread / facial ACD (e.g., poison ivy)

  • Oral prednisone 0.5-1 mg/kg/day tapered over 2-3 weeks (NOT a Medrol Dose Pack — rebound is common with short tapers <14 days)
  • Short course IV/IM corticosteroid (e.g., triamcinolone IM) acceptable alternative

Chronic occupational hand dermatitis

  • Job modification, gloves (vinyl/nitrile over cotton liners), barrier creams, frequent moisturizing
  • Refractory: phototherapy (narrowband UVB, PUVA), oral alitretinoin (where available), dupilumab

Second-line / adjunct

  • Antibiotic only if secondary bacterial infection — cephalexin, dicloxacillin
  • Topical antipruritic: pramoxine, menthol
  • Refer to occupational medicine for workers' compensation documentation

Complications

  • Secondary bacterial infection (S. aureus, S. pyogenes)
  • Post-inflammatory hyperpigmentation, especially Fitzpatrick IV-VI
  • Chronic occupational hand dermatitis → job loss, disability
  • Erythroderma in widespread severe cases
  • Steroid-induced atrophy with prolonged high-potency topical use

PANCE pearls

  • Linear streaky vesicles after hiking = poison ivy / oak / sumac (urushiol). The fluid in vesicles does NOT spread the rash; new lesions reflect different exposure doses absorbed at different rates.
  • Eyelid dermatitis from nail polish (tosylamide formaldehyde resin) is classic — patient touches eyes with allergen-coated nails.
  • Nickel patch testing is positive in ~15-20% of women and ~5% of men; the dimethylglyoxime spot test identifies nickel-releasing metal jewelry.
  • Topical neomycin and bacitracin are common ACD culprits — avoid prophylactic 'triple antibiotic' on clean wounds; petrolatum is sufficient.
  • Oral prednisone for poison ivy MUST be tapered ≥14-21 days; shorter courses cause rebound.
  • Toxicodendron prevention when exposure cannot be avoided: wash exposed skin (including under the nails) with soap and water as soon as possible, because urushiol binds within minutes; wash clothing, gloves and tools, where the resin stays active for a long time; bentoquatam 5% lotion applied before exposure is a barrier option; never burn the plants (smoke carries urushiol into the airway).

References

  • AAD/ACDS 2020 — American Contact Dermatitis Society Core Allergen Series (Schalock et al., Dermatitis 2020)
  • NACDG — North American Contact Dermatitis Group Patch-Test Results Periodic Reports (DeKoven et al., Dermatitis)
  • BAD 2017 — British Association of Dermatologists' Guidelines for the Management of Contact Dermatitis 2017 (Johnston GA, Exton LS, Mohd Mustapa MF, et al., Br J Dermatol 2017;176(2):317-329)

Practice Dermatology questions on FirstPassPA

Turn this outline into retention. 7,700+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start your 7-day free trial → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.